Identification of β-arrestin2 as a G protein-coupled receptor-stimulated regulator of NF-κB pathways

Molecular Cell

Volumn 14, Issue 3, 2004, Pages 303-317

  Gao, Hua ^a   Sun, Yue ^a   Wu, Yalan ^a   Luan, Bing ^a   Wang, Yaya ^a   Qu, Bin ^a   Pei, Gang ^a  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ARRESTIN; G PROTEIN COUPLED RECEPTOR; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN;

ADRENERGIC SYSTEM; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; GENE TARGETING; HUMAN; HUMAN CELL; IMMUNE SYSTEM; NONHUMAN; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; STIMULATION;

ARRESTINS; CELL LINE; GENE EXPRESSION REGULATION; HUMANS; I-KAPPA B PROTEINS; MUTATION; NEUROIMMUNOMODULATION; NF-KAPPA B; PHOSPHORYLATION; PROTEIN STRUCTURE, TERTIARY; RECEPTORS, ADRENERGIC, BETA-2; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; SYMPATHETIC NERVOUS SYSTEM;

ANIMALIA;

EID: 2342510314     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1097-2765(04)00216-3     Document Type: Article

References (47)

1. Anest V., Hanson J.L., Cogswell P.C., Steinbrecher K.A., Strahl B.D., Baldwin A.S. A nucleosomal function for IkappaB kinase-alpha in NF-kappaB-dependent gene expression. Nature. 423:2003;659-663
2. Baldwin A.S. Jr. The NF-kappa B and I kappa B proteins. new discoveries and insights Annu. Rev. Immunol. 14:1996;649-683
3. Baldwin A.S. Jr. Series introduction. the transcription factor NF-kappaB and human disease J. Clin. Invest. 107:2001;3-6
4. Barlic J., Andrews J.D., Kelvin A.A., Bosinger S.E., DeVries M.E., Xu L., Dobransky T., Feldman R.D., Ferguson S.S., Kelvin D.J. Regulation of tyrosine kinase activation and granule release through beta-arrestin by CXCRI. Nat. Immunol. 1:2000;227-233
5. Bhattacharya M., Anborgh P.H., Babwah A.V., Dale L.B., Dobransky T., Benovic J.L., Feldman R.D., Verdi J.M., Rylett R.J., Ferguson S.S. Beta-arrestins regulate a Ral-GDS Ral effector pathway that mediates cytoskeletal reorganization. Nat. Cell Biol. 4:2002;547-555
6. Brown K., Gerstberger S., Carlson L., Franzoso G., Siebenlist U. Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation. Science. 267:1995;1485-1488
7. Cen B., Xiong Y., Ma L., Pei G. Direct and differential interaction of beta-arrestins with the intracellular domains of different opioid receptors. Mol. Pharmacol. 59:2001;758-764
8. Chen L.W., Egan L., Li Z.W., Greten F.R., Kagnoff M.F., Karin M. The two faces of IKK and NF-kappaB inhibition. prevention of systemic inflammation but increased local injury following intestinal ischemia-reperfusion Nat. Med. 9:2003;575-581
9. Dignam J.D., Lebovitz R.M., Roeder R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1983;1475-1489
10. Downing J.E., Miyan J.A. Neural immunoregulation. emerging roles for nerves in immune homeostasis and disease Immunol. Today. 21:2000;281-289
11. Elenkov I.J., Wilder R.L., Chrousos G.P., Vizi E.S. The sympathetic nerve - an integrative interface between two supersystems. the brain and the immune system Pharmacol. Rev. 52:2000;595-638
12. Farmer P., Pugin J. beta-adrenergic agonists exert their "anti-inflammatory" effects in monocytic cells through the IkappaB/NF-kappaB pathway. Am. J. Physiol. Lung Cell. Mol. Physiol. 279:2000;L675-L682
13. Fenwick C., Na S.Y., Voll R.E., Zhong H., Im S.Y., Lee J.W., Ghosh S. A subclass of Ras proteins that regulate the degradation of IkappaB. Science. 287:2000;869-873
14. Fong A.M., Premont R.T., Richardson R.M., Yu Y.R., Lefkowitz R.J., Patel D.D. Defective lymphocyte chemotaxis in beta-arrestin2- and GRK6-deficient mice. Proc. Natl. Acad. Sci. USA. 99:2002;7478-7483
15. Ghosh S., Karin M. Missing pieces in the NF-kappaB puzzle. Cell. 109(Suppl):2002;S81-S96
16. Goodman O.B. Jr., Krupnick J.G., Santini F., Gurevich V.V., Penn R.B., Gagnon A.W., Keen J.H., Benovic J.L. Beta-arrestin acts as a clathrin adaptor in endocytosis of the beta2-adrenergic receptor. Nature. 383:1996;447-450
17. Israel A. The IKK complex. an integrator of all signals that activate NF-kappaB? Trends Cell Biol. 10:2000;129-133
18. Karin M., Ben-Neriah Y. Phosphorylation meets ubiquitination. the control of NF-[kappa]B activity Annu. Rev. Immunol. 18:2000;621-663
19. Karin M., Lin A. NF-kappaB at the crossroads of life and death. Nat. Immunol. 3:2002;221-227
20. Kim Y.M., Barak L.S., Caron M.G., Benovic J.L. Regulation of arrestin-3 phosphorylation by casein kinase II. J. Biol. Chem. 277:2002;16837-16846
21. Koff W.C., Fann A.V., Dunegan M.A., Lachman L.B. Catecholamine-induced suppression of interleukin-1 production. Lymphokine Res. 5:1986;239-247
22. Kohm A.P., Sanders V.M. Norepinephrine and beta 2-adrenergic receptor stimulation regulate CD4+ T and B lymphocyte function in vitro and in vivo. Pharmacol. Rev. 53:2001;487-525
23. Li Q., Verma I.M. NF-kappaB regulation in the immune system. Nat. Rev. Immunol. 2:2002;725-734
24. Lin F.T., Chen W., Shenoy S., Cong M., Exum S.T., Lefkowitz R.J. Phosphorylation of beta-arrestin2 regulates its function in internalization of beta(2)-adrenergic receptors. Biochemistry. 41:2002;10692-10699
25. Lin L., Spoor M.S., Gerth A.J., Brody S.L., Peng S.L. Modulation of Th1 activation and inflammation by the NF-kappaB repressor Foxj1. Science. 303:2004;1017-1020
26. Luttrell L.M., Lefkowitz R.J. The role of beta-arrestins in the termination and transduction of G-protein-coupled receptor signals. J. Cell Sci. 115:2002;455-465
27. Luttrell L.M., Ferguson S.S., Daaka Y., Miller W.E., Maudsley S., Della Rocca G.J., Lin F., Kawakatsu H., Owada K., Luttrell D.K., et al. Beta-arrestin-dependent formation of beta2 adrenergic receptor-Src protein kinase complexes. Science. 283:1999;655-661
28. Madden K.S., Sanders V.M., Felten D.L. Catecholamine influences and sympathetic neural modulation of immune responsiveness. Annu. Rev. Pharmacol. Toxicol. 35:1995;417-448
29. Marinissen M.J., Gutkind J.S. G-protein-coupled receptors and signaling networks. emerging paradigms Trends Pharmacol. Sci. 22:2001;368-376
30. McDonald P.H., Chow C.W., Miller W.E., Laporte S.A., Field M.E., Lin F.T., Davis R.J., Lefkowitz R.J. Beta-arrestin 2. a receptor-regulated MAPK scaffold for the activation of JNK3 Science. 290:2000;1574-1577
31. Oakley R.H., Laporte S.A., Holt J.A., Caron M.G., Barak L.S. Differential affinities of visual arrestin, beta arrestin1, and beta arrestin2 for G protein-coupled receptors delineate two major classes of receptors. J. Biol. Chem. 275:2000;17201-17210
32. Perry S.J., Lefkowitz R.J. Arresting developments in heptahelical receptor signaling and regulation. Trends Cell Biol. 12:2002;130-138
33. Perry S.J., Baillie G.S., Kohout T.A., McPhee I., Magiera M.M., Ang K.L., Miller W.E., McLean A.J., Conti M., Houslay M.D., et al. Targeting of cyclic AMP degradation to beta 2-adrenergic receptors by beta-arrestins. Science. 298:2002;834-836
34. Rockman H.A., Koch W.J., Lefkowitz R.J. Seven-transmembrane-spanning receptors and heart function. Nature. 415:2002;206-212
35. Scott M.G., Le Rouzic E., Perianin A., Pierotti V., Enslen H., Benichou S., Marullo S., Benmerah A. Differential nucleocytoplasmic shuttling of beta-arrestins. Characterization of a leucine-rich nuclear export signal in beta-arrestin2. J. Biol. Chem. 277:2002;37693-37701
36. Silverman N., Maniatis T. NF-kappaB signaling pathways in mammalian and insect innate immunity. Genes Dev. 15:2001;2321-2342
37. Small K.M., McGraw D.W., Liggett S.B. Pharmacology and physiology of human adrenergic receptor polymorphisms. Annu. Rev. Pharmacol. Toxicol. 43:2003;381-411
38. Sun Y., Cheng Z., Ma L., Pei G. Beta-arrestin2 is critically involved in CXCR4-mediated chemotaxis, and this is mediated by its enhancement of p38 MAPK activation. J. Biol. Chem. 277:2002;49212-49219
39. van der Poll T., Jansen J., Endert E., Sauerwein H.P., van Deventer S.J. Noradrenaline inhibits lipopolysaccharide-induced tumor necrosis factor and interleukin 6 production in human whole blood. Infect. Immun. 62:1994;2046-2050
40. Walker J.K., Fong A.M., Lawson B.L., Savov J.D., Patel D.D., Schwartz D.A., Lefkowitz R.J. Beta-arrestin-2 regulates the development of allergic asthma. J. Clin. Invest. 112:2003;566-574
41. Wang P., Gao H., Ni Y., Wang B., Wu Y., Ji L., Qin L., Ma L., Pei G. Beta-arrestin 2 functions as a G-protein-coupled receptor-activated regulator of oncoprotein Mdm2. J. Biol. Chem. 278:2003;6363-6370. a
42. Wang P., Wu Y., Ge X., Ma L., Pei G. Subcellular localization of beta-arrestins is determined by their intact N domain and the nuclear export signal at the C terminus. J. Biol. Chem. 278:2003;11648-11653. b
43. Webster J.I., Tonelli L., Sternberg E.M. Neuroendocrine regulation of immunity. Annu. Rev. Immunol. 20:2002;125-163
44. Whiteside S.T., Ernst M.K., LeBail O., Laurent-Winter C., Rice N., Israel A. N- and C-terminal sequences control degradation of MAD3/I kappa B alpha in response to inducers of NF-kappa B activity. Mol. Cell. Biol. 15:1995;5339-5345
45. Xiang Y., Kobilka B.K. Myocyte adrenoceptor signaling pathways. Science. 300:2003;1530-1532
46. Yamamoto Y., Verma U.N., Prajapati S., Kwak Y.T., Gaynor R.B. Histone H3 phosphorylation by IKK-alpha is critical for cytokine-induced gene expression. Nature. 423:2003;655-659
47. Ye R.D. Regulation of nuclear factor kappaB activation by G-protein-coupled receptors. J. Leukoc. Biol. 70:2001;839-848